Capstone Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Capstone Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$269K	Sell	16,739 -2,040	-11%	-$30.1K	0.01%	1342
2017 Q1	$238K	Sell	18,779 -1,990	-10%	-$24K	0.01%	1446
2016 Q4	$275K	Sell	20,769 -3,390	-14%	-$58K	0.01%	1368
2016 Q3	$573K	Buy	24,159 +660	+3%	+$17.7K	0.02%	865
2016 Q2	$677K	Buy	23,499 +1,850	+9%	+$60.3K	0.02%	756
2016 Q1	$693K	Sell	21,649 -740	-3%	-$26K	0.02%	722
2015 Q4	$957K	Buy	22,389 +420	+2%	+$16.8K	0.03%	617
2015 Q3	$774K	Buy	21,969 +1,410	+7%	+$63.5K	0.02%	649
2015 Q2	$944K	Sell	20,559 -12,830	-38%	-$609K	0.03%	608
2015 Q1	$1.56M	Buy	33,389 +1,870	+6%	+$74.4K	0.04%	483
2014 Q4	$999K	Buy	31,519 +3,460	+12%	+$101K	0.03%	643
2014 Q3	$665K	Sell	28,059 -270	-1%	-$6.92K	0.02%	824
2014 Q2	$850K	Buy	28,329 +3,794	+15%	+$102K	0.03%	693
2014 Q1	$648K	Sell	24,535 -1,450	-6%	-$36.2K	0.02%	867
2013 Q4	$653K	Sell	25,985 -13,821	-35%	-$308K	0.02%	907
2013 Q3	$815K	Buy	39,806 +1,800	+5%	+$37.2K	0.02%	918
2013 Q2	$758K	Buy	+38,006	New	+$675K	0.02%	892

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Capstone Asset Management's IPXL Position: Q2 2017 in Review

Capstone Asset Management reduced its Impax Laboratories, Inc. (IPXL) stake by 11% in Q2 2017, selling an estimated $30.1K and leaving 16,739 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #1342.

Capstone Asset Management first reported a position in IPXL in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.56M in Q1 2015. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

Capstone Asset Management held 16,739 shares of Impax Laboratories, Inc. worth $269K as of Q2 2017.
Capstone Asset Management sold 2,040 Impax Laboratories, Inc. shares in Q2 2017, an estimated $30.1K.
Impax Laboratories, Inc. made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1342 holding.
Capstone Asset Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 17 quarters since.
Capstone Asset Management's Impax Laboratories, Inc. position peaked at $1.56M in Q1 2015.
172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.